Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer

NCT06103617 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Recurrent Cancer

Interventions

DRUG: Penicillamine

Sponsor

Nanfang Hospital, Southern Medical University